Further acquisition for Nycomed, which buys Colombian company Farmacol

4 February 2011

Fast growing independent Swiss drugmaker Nycomed says that it is expanding its presence in Latin America through the purchase of Laboratorios Farmacol SA, a Colombia based, family-owned pharmaceutical company, which has a strong presence in the areas of gastroenterology, respiratory and gynecology. The company declined The Pharma Letter’s request to reveal financial terms of the deal, but said it is subject to regulatory approval but is expected to close in the second quarter of this year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical